PMA supplement

P970003 S180: DEMIPULSE MODEL 103 GENERATOR AND ASPIRESR MODEL 106 GENERATOR

FDA PMA supplement · 30-Day Notice · LivaNova USA, Inc.

Key facts

Original PMA P970003
Supplement number S180
Supplement type 30-Day Notice
Reason for the supplement Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name DEMIPULSE MODEL 103 GENERATOR AND ASPIRESR MODEL 106 GENERATOR
Generic name Stimulator, autonomic nerve, implanted (depression)
Applicant LivaNova USA, Inc.
Product code MUZ
Received date Jun 8, 2015
Decision date Jul 8, 2015

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements